Denali Therapeutics Inc. (DNLI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 44.51 |
| Open | 44.44 |
| Bid | 3.00 x 800 |
| Ask | 55.00 x 1100 |
| Day's range | 41.71 - 44.44 |
| 52-week range | 41.71 - 93.94 |
| Volume | |
| Avg. volume | 506,036 |
| Market cap | 5.161B |
| Beta (5Y monthly) | 1.88 |
| PE ratio (TTM) | 86.57 |
| EPS (TTM) | 0.49 |
| Earnings date | 23 Feb 2022 - 28 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 86.60 |
- Zacks
Denali (DNLI) Stock Up Despite Wider-Than-Expected Q3 Loss
Denali (DNLI) announces wider-than-expected loss per share for third-quarter 2021. Nonetheless, its shares rise following the announcement.
- Zacks
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Misses Revenue Estimates
Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of -35.29% and -78.45%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Denali Therapeutics (NASDAQ:DNLI) shareholder returns have been impressive, earning 206% in 3 years
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
© 2021 Yahoo. All rights reserved.
